The Manufacturers Life Insurance Company acquired a new stake in shares of VBI Vaccines, Inc. – (NASDAQ:VBIV) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 29,509 shares of the biopharmaceutical company’s stock, valued at approximately $126,000.
Other hedge funds also recently modified their holdings of the company. California State Teachers Retirement System purchased a new stake in VBI Vaccines during the second quarter valued at approximately $167,000. Schwab Charles Investment Management Inc. raised its holdings in shares of VBI Vaccines by 36.0% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 58,200 shares of the biopharmaceutical company’s stock worth $249,000 after buying an additional 15,400 shares during the period. State Street Corp purchased a new stake in shares of VBI Vaccines in the second quarter worth approximately $831,000. Northern Trust Corp purchased a new stake in shares of VBI Vaccines in the second quarter worth approximately $883,000. Finally, Russell Investments Group Ltd. purchased a new stake in shares of VBI Vaccines in the third quarter worth approximately $1,329,000. Institutional investors and hedge funds own 48.64% of the company’s stock.
Shares of VBI Vaccines stock opened at $3.67 on Friday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.26 and a current ratio of 5.32. VBI Vaccines, Inc. – has a fifty-two week low of $3.04 and a fifty-two week high of $5.72.
TRADEMARK VIOLATION WARNING: This article was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.tickerreport.com/banking-finance/3299313/the-manufacturers-life-insurance-company-acquires-new-stake-in-vbi-vaccines-inc-vbiv.html.
VBI Vaccines Company Profile
VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various projects related to human cytomegalovirus (CMV) and other antigens.
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.